Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
Risk Stratification of Patients Presenting With Upper Gastrointestinal Bleeding to the Emergency Department Using AIMS65 Score and Red Cell Distribution Width
The rationale of this study in UGIB patients is to assess whether the prediction of mortality
 and morbidity using AIMS65 score improves when used in combination with RDW in the emergency
 department setting.
UGIB is a ticking time-bomb and emergency physicians are challenged to accurately assess
 risk, and aggressively manage patients with gastrointestinal bleeding within the stipulated
 time in the confines of emergency department. If not managed properly, it is associated with
 high mortality.

 Various clinical prediction scores help in risk stratifying such patients. Among the scores,
 AIMS65 score is the easy to use score and has good mortality predictive accuracy. RDW, once
 thought as marker of chronic blood loss has recently been identified as a good prognostic
 indicator as well as good predictor of mortality in conditions where there is acute blood
 loss.

 Both AIMS65 score and RDW value have been used separately as a predictor of morbidity and
 mortality in patients with UGIB. But there are not much studies so far evaluating their
 combined role as marker of predicting mortality as well as high risk among UGIB patients.
 Hence there is a need for a study to know the predictive value of combination of AIMS6S score
 and RDW in patients presenting to ED with symptoms of UGIB not been much studies comparing
 the relationship between RDW and upper GI bleed.

 The rationale of this study in UGIB patients is to assess whether the prediction of mortality
 and morbidity using AIMS65 score improves when used in combination with RDW in the emergency
 department setting.
Inclusion Criteria:

 1. All patients presenting to ED with UGIB

 2. Age more than 18 years of age

 Exclusion Criteria:

 1. Patients not consenting to study

 2. Patients with known hematological disorders

 3. Patients in which endoscopy or blood transfusion is done outside

 4. Patients in which RDW value and laboratory parameters required for AIMS65 score are
 not available.